CBFA2T1 adenovirus

The CBFA2T1 (core binding factor, runt domain, alpha subunit 2, translocation to 1) gene, also known as ETO or MTG8, is a key transcriptional regulator involved in hematopoiesis, cell differentiation, and tumorigenesis. CBFA2T1 is located on chromosome 8q21 and encodes a nuclear protein that functions as a transcriptional corepressor by interacting with histone deacetylases (HDACs) and other chromatin-modifying complexes. It plays a key role in repressing target genes associated with cell proliferation and survival. Notably, CBFA2T1 is frequently associated with chromosomal translocations, such as the t(8;21) translocation in acute myeloid leukemia (AML), where it fuses with the RUNX1 gene and disrupts normal hematopoietic differentiation. In addition to its oncogenic potential, CBFA2T1 is essential for embryonic development and tissue homeostasis.

The CBFA2T1 adenovirus is a recombinant viral vector designed to deliver the CBFA2T1 gene to target cells for research or therapeutic purposes. Adenoviral vectors are widely used in gene therapy due to their high transduction efficiency, broad tropism, and ability to infect both dividing and non-dividing cells. The CBFA2T1 adenovirus is particularly important for studying the role of this gene in processes such as cell differentiation, apoptosis, and cancer progression. In an experimental setting, this vector can achieve overexpression of CBFA2T1, allowing researchers to study its regulatory mechanisms and its potential as a therapeutic target. Although clinical applications are still in the exploratory stage, the CBFA2T1 adenovirus has the potential to treat malignancies associated with CBFA2T1 dysregulation, such as acute myeloid leukemia (AML), by restoring normal transcriptional regulation.